Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.7.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Operating expenses    
Research and development $ 939,040 $ 576,093
General and administrative 3,531,540 3,741,017
Total operating expenses 4,470,580 4,317,110
Operating loss (4,470,580) (4,317,110)
Other expense (income)    
Change in fair value of warrant liability (1,342,651) (481,610)
Net Loss before income taxes (3,176,493) (4,839,445)
Provision for income taxes 1,600 1,716
Net loss (3,178,093) (4,841,161)
Less: Preferred deemed dividend 325,000  
Net loss applicable to common shareholders $ (3,503,093) $ (4,841,161)
Basic and diluted loss per common share (in dollars per share) $ (0.17) $ (0.29)
Shares used in computing basic and diluted loss per share (in shares) 18,947,375 16,938,318
Series A Preferred stock    
Other expense (income)    
Change in fair value of conversion rights $ 986,000
Series B Preferred Stock    
Other expense (income)    
Change in fair value of conversion rights $ 48,564 $ 17,945